Examining Risk: Differing CGT Funding Strategies Within Europe, the US & Asia

06 Sep 2023
11:00

11:00am Chair Introduction 

Ann-Hunter Van Kirk, Senior Equity Research Analyst, Bloomberg 

 

11:05am Presentation: Title to be Confirmed 

  • Presentation content to be added

Matthieu Coutet, Managing Partner, AdBio 

  

11:20am Presentation: Title to be Confirmed 

  • Presentation content to be added

Presenter to be Confirmed 

  

11:35am Presentation: Title to be Confirmed 

  • Presentation content to be added

Eric Halioua, President & Chief Executive Officer, PDC Line Pharma 

  

11:50am Presentation: Title to be Confirmed 

  • Presentation content to be added 

Ingrid Gafanhão, Equity Research Analyst, Healthcare, Bryan, Garnier & Co.  

  

12:05pm Closing Panel with Q&A 

With all session participants 

Speakers

Ann-Hunter Van Kirk
Senior Equity Research Analyst Biopharmaceuticals
Bloomberg Intelligence
Matthieu Coutet
Managing Partner
AdBio Partners
Eric Halioua
President & Chief Executive Officer
PDC*Line Pharma
Ingrid Gafanhão
Equity Research Analyst, Healthcare
Bryan, Garnier & Co